Literature DB >> 18842395

Lactoferrin: structure, function and applications.

Susana A González-Chávez1, Sigifredo Arévalo-Gallegos, Quintín Rascón-Cruz.   

Abstract

Lactoferrin (LF) is an 80 kDa iron-binding glycoprotein of the transferrin family that is expressed in most biological fluids and is a major component of the mammalian innate immune system. Its protective effects range from direct antimicrobial activities against a large panel of microorganisms, including bacteria, viruses, fungi and parasites, to anti-inflammatory and anticancer activities. These extensive activities are made possible by mechanisms of action utilising not only the capacity of LF to bind iron but also interactions of LF with molecular and cellular components of both host and pathogens. This review summarises the putative antimicrobial mechanisms, clinical applications and heterologous expression models for LF.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18842395     DOI: 10.1016/j.ijantimicag.2008.07.020

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  107 in total

1.  Positive selection drives lactoferrin evolution in mammals.

Authors:  Guo Ming Liang; Xun Ping Jiang
Journal:  Genetica       Date:  2010-04-18       Impact factor: 1.082

2.  Efficacy and safety of oral lactoferrin supplementation in combination with rHuEPO-beta for the treatment of anemia in advanced cancer patients undergoing chemotherapy: open-label, randomized controlled study.

Authors:  Antonio Macciò; Clelia Madeddu; Giulia Gramignano; Carlo Mulas; Eleonora Sanna; Giovanni Mantovani
Journal:  Oncologist       Date:  2010-07-20

3.  Many Roles of CCL20: Emphasis on Breast Cancer.

Authors:  Kingsley O Osuala; Bonnie F Sloane
Journal:  Postdoc J       Date:  2014-03

Review 4.  Keratoconus: an inflammatory disorder?

Authors:  V Galvis; T Sherwin; A Tello; J Merayo; R Barrera; A Acera
Journal:  Eye (Lond)       Date:  2015-05-01       Impact factor: 3.775

5.  Lactoferrin suppresses the Epstein-Barr virus-induced inflammatory response by interfering with pattern recognition of TLR2 and TLR9.

Authors:  Ying Zheng; Zailong Qin; Qiurong Ye; Pan Chen; Zhen Wang; Qun Yan; Zhaohui Luo; Xiaoping Liu; Yanhong Zhou; Wei Xiong; Jian Ma; Guiyuan Li
Journal:  Lab Invest       Date:  2014-07-28       Impact factor: 5.662

Review 6.  Antimicrobial peptides with cell-penetrating peptide properties and vice versa.

Authors:  Katrin Splith; Ines Neundorf
Journal:  Eur Biophys J       Date:  2011-02-19       Impact factor: 1.733

7.  Porcine and Bovine Forms of Lactoferrin Inhibit Growth of Porcine Enterotoxigenic Escherichia coli and Degrade Its Virulence Factors.

Authors:  Bert Devriendt; Eric Cox; Matthias Dierick; Hans Van der Weken; Joanna Rybarczyk; Daisy Vanrompay
Journal:  Appl Environ Microbiol       Date:  2020-11-24       Impact factor: 4.792

8.  Stability of lactoferrin in stored human milk.

Authors:  D E Rollo; P G Radmacher; R M Turcu; S R Myers; D H Adamkin
Journal:  J Perinatol       Date:  2014-02-06       Impact factor: 2.521

9.  Oral lactoferrin protects against experimental candidiasis in mice.

Authors:  K Velliyagounder; W Alsaedi; W Alabdulmohsen; K Markowitz; D H Fine
Journal:  J Appl Microbiol       Date:  2014-11-25       Impact factor: 3.772

10.  Enzymatically cross-linked bovine lactoferrin as injectable hydrogel for cell delivery.

Authors:  Ashley A Amini; Ho-Man Kan; Zhanwu Cui; Peter Maye; Lakshmi S Nair
Journal:  Tissue Eng Part A       Date:  2014-06-16       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.